Starpharma Holdings Limited Share Price Other OTC
Equities
SPHRY
US8555631022
Pharmaceuticals
Sales 2022 | 5.16M 3.43M 286M | Sales 2023 | 4.21M 2.8M 233M | Capitalization | 127M 84.62M 7.06B |
---|---|---|---|---|---|
Net income 2022 | -16M -10.64M -887M | Net income 2023 | -15M -9.98M -832M | EV / Sales 2022 | 50.5 x |
Net cash position 2022 | 41.73M 27.75M 2.31B | Net cash position 2023 | 26.91M 17.89M 1.49B | EV / Sales 2023 | 23.8 x |
P/E ratio 2022 |
-18.5
x | P/E ratio 2023 |
-7.75
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 92.55% |
Managers | Title | Age | Since |
---|---|---|---|
Cheryl Maley
CEO | Chief Executive Officer | - | 08/01 |
Justin Cahill
DFI | Director of Finance/CFO | - | 03/23/03 |
Tony Eglezos
PRN | Corporate Officer/Principal | - | 12/13/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Davies
BRD | Director/Board Member | - | 01/22/01 |
Robert Thomas
CHM | Chairman | 79 | 04/13/04 |
David McIntyre
BRD | Director/Board Member | 53 | 01/20/01 |
1st Jan change | Capi. | |
---|---|---|
+55.95% | 811B | |
+43.62% | 640B | |
-6.98% | 353B | |
+19.08% | 333B | |
+9.05% | 302B | |
+16.30% | 246B | |
+2.41% | 225B | |
+12.47% | 218B | |
+8.91% | 168B |